This review summarizes recent progress in the development of myostatin inhibitors for the treatment of muscle wasting disorders. It also focuses on findings in myostatin biology that may have implications for the development of antimyostatin therapies.
Recent findings
There has been progress...
antimyostatin
atrophied
cell
development
disorders
force
hypertrophy
inhibition
leads
mice
muscle
myostatin
number
observed
progress
proliferation
recent
results
satellite
specific
strategy
therapeutic
therapies
total
wasting
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.